Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Phytopharm Plc
Download detailed PDF Members: Phytopharm is making good progress in developing a broad portfolio of products with substantial potential value. We are progressing to the second stage of our obesity programme with Unilever and Schering-Plough is in the process of launching Phytopica™ in the UK as an effective aid to the management of canine atopic dermatitis as a part of its global marketing deal.Our plant extract division is now generating significant revenue and we continue to invest in the pharmaceutical division of the Company. Full confidential disclosure of the substantial data sets for both Cogane™ and Myogane™, our lead products for Alzheimer’s and motor neurone disease, are now in progress with interested potential licensing partners.
This page has been viewed 347 times since April 2007, the link to the organisation's website has been followed 44 times Search for more companies in Godmanchester Search for more companies in Cambridgeshire This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Phytopharm Plc | |||||||||||||||||||||||||||||||||||||||||||||||||
|